• About Us About Us
    • Our Mission
    • Our Team
  • Our Science Our Science
    • EnC-LNPs
    • LNPs
    • Publications
  • Our Pipeline Our Pipeline
  • News & Events News & Events
  • Contact Us Contact Us
  • EN
  • CN

Publications

  • Home >> Our Science >> Publications
  • EnC-LNPs
  • LNPs
  • Publications
Antiviral Research

Mpox virus mRNA-lipid nanoparticle vaccine candidates evoke antibody responses and drive protection against the Vaccinia virus challenge in mice

Advanced Healthcare Materials

Delivery of mRNA Vaccine with 1,2-diesters-derived Lipids Elicits Fast Liver Clearance for Safe and Effective Cancer Immunotherapy

OncoImmunology

Novel mRNA adjuvant ImmunER enhances prostate cancer tumor-associated antigen mRNA therapy via augmenting T cell activity

Pharmaceutics

α-Lactalbumin mRNA-LNP Evokes an Anti-Tumor Effect Combined with Surgery in Triple-Negative Breast Cancer.

Acta Biomater

Personalized membrane protein vaccine based on a lipid nanoparticle delivery system prevents postoperative recurrence in colorectal cancer models

  • Pre
  • Next
  • Last
  • 1Pages

虹信生物

  • About Us
  • Our Science
  • Our Pipeline
  • News & Events
Focusing on Nucleic Acid Drug Delivery, Benefitting Patients with RNA Therapies  Copyright © MagicRNA All Rights Reserved.   粤ICP备2023022739号   
MagicRNA
401, Building C5, No. 459, Qiaokai Road, Guangming District, Shenzhen, Guangdong, China
Contact Us
Tel+86-755-27109036
E-mailinfo@magicrna.com